STC
VIRX

SEI Trust Company’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

SEI Trust Company’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$218K Sell
146
-63
-30% -$91.2K ﹤0.01% 1294
2014
Q2 		$286K Buy
209
+37
+22% +$42.9K ﹤0.01% 1234
2014
Q1 		$238K Buy
+172
New +$200K ﹤0.01% 1262

Other funds holding VIRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCP
Lamond Capital Partners San Francisco, California $14.3M AUM 30.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SEI Trust Company's VIRX Position: Q3 2014 in Review

SEI Trust Company reduced its Viracta Therapeutics, Inc. Common Stock (VIRX) stake by 30% in Q3 2014, selling an estimated $91.2K and leaving 146 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1294.

SEI Trust Company first reported a position in VIRX in Q1 2014 and has held it in 3 quarters since. The position peaked at $286K in Q2 2014. 104 funds tracked by Wall St. Rank hold VIRX as of Q3 2014.

  • SEI Trust Company held 146 shares of Viracta Therapeutics, Inc. Common Stock worth $218K as of Q3 2014.
  • SEI Trust Company sold 63 Viracta Therapeutics, Inc. Common Stock shares in Q3 2014, an estimated $91.2K.
  • Viracta Therapeutics, Inc. Common Stock made up ﹤0.01% of SEI Trust Company's portfolio in Q3 2014, its #1294 holding.
  • SEI Trust Company first reported a position in Viracta Therapeutics, Inc. Common Stock in Q1 2014 and has held it in 3 quarters since.
  • SEI Trust Company's Viracta Therapeutics, Inc. Common Stock position peaked at $286K in Q2 2014.
  • 104 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.